1356P - The level of circulating NKp46+ CD56dim CD16+ natural killer cells predicts distinct survival in non-small cell lung cancer

Autor: Picard, E., Godet, Y., Laheurte, C., Boullerot, L., Lauret Marie Joseph, E., Jacquin, M., Kaulek, V., Eberst, G., Gaugler, B., Jacoulet, P., Gainet-Brun, M., Lahoucarde, J., Almotlak, H., Le Pimpec-Barthes, F., Fabre-Guillevin, E., Borg, C., Westeel, V., Adotevi, O.

Publikováno v: In Annals of Oncology October 2018 29 Supplement 8

Étude des mécanismes impliqués dans la modulation des réponses immunitaires T antitumorales induites par la radio-chimiothérapie concomitante (RTCTc)

Autor: Lauret Marie Joseph, E., Bonin, C., Rangan, L., Boullerot, L., Vrecko, S., Boustani, J., Laheurte, C., Mirjolet, C., Servagi, S., Adotevi, O.

Publikováno v: In Revue des Maladies Respiratoires January 2017 34 Supplement:A327-A328

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy.

Autor: Lauret Marie Joseph E; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Kirilovsky A; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Lecoester B; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., El Sissy C; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Boullerot L; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Rangan L; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Marguier A; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Tochet F; Department of Radiation Oncology, CHU Besançon, Besançon, France., Dosset M; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Boustani J; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France.; Department of Radiation Oncology, CHU Besançon, Besançon, France., Ravel P; Equipe Bioinformatique et Biologie des Systèmes du Cancer, Institut de Recherche en Cancérologie de Montpellier-INSERM U1194, Montpellier, France., Boidot R; Department of Biology and Pathology of Tumors, Georges-François Leclerc Cancer Center, Dijon, France., Spehner L; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Haicheur-Adjouri N; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Marliot F; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Pallandre JR; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Bonnefoy F; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Scripcariu V; Department of Surgical Oncology, Regional Institute of Oncology Iaşi, Iasi, Romania., Van den Eynde M; Cliniques universitaires Saint-Luc Institut Roi Albert II, Bruxelles, Belgium., Cornillot E; Cancer Bioinformatics and Systems Biology, IRCM, Montpellier, France.; Faculté de Pharmacie, Université de Montpellier, Montpellier, France., Mirjolet C; Department of Radiation Oncology, Georges-Francois Leclerc Cancer Center, Dijon, France.; INSERM UMR 1231, Dijon, France., Pages F; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Adotevi O; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France olivier.adotevi@univ-fcomte.fr.; Department of Medical Oncology, CHU Besançon, Besançon, France.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jul; Vol. 9 (7).

Circulating NKp46 ⁺ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.

Autor: Picard E; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Godet Y; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Laheurte C; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France.; University Hospital of Besançon, INSERM CIC-1431 Clinical Investigation Center in Biotherapies, Besançon, France., Dosset M; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Galaine J; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Beziaud L; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Loyon R; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Boullerot L; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Lauret Marie Joseph E; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Spehner L; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Jacquin M; University Hospital of Besançon, INSERM CIC-1431 Clinical Investigation Center in Biotherapies, Besançon, France., Eberst G; University Hospital of Besançon, Department of Pneumology, Besançon, France., Gaugler B; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Le Pimpec-Barthes F; Service de Chirurgie Thoracique, AP-HP, Hôpital Européen Georges Pompidou, Paris, France., Fabre E; Service d'Oncologie Médicale, AP-HP, Hôpital Européen Georges Pompidou, Paris, France., Westeel V; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France.; University Hospital of Besançon, Department of Pneumology, Besançon, France., Caignard A; INSERM, UMR1160, Institut Universitaire d'hématologie, Paris, France., Borg C; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France.; University Hospital of Besançon, Department of Medical Oncology, Besançon, France., Adotévi O; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France.; University Hospital of Besançon, Department of Medical Oncology, Besançon, France.

Publikováno v: Oncoimmunology [Oncoimmunology] 2018 Oct 19; Vol. 8 (2), pp. e1527498. Date of Electronic Publication: 2018 Oct 19 (Print Publication: 2019).